JP2000053526A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JP2000053526A JP2000053526A JP10232343A JP23234398A JP2000053526A JP 2000053526 A JP2000053526 A JP 2000053526A JP 10232343 A JP10232343 A JP 10232343A JP 23234398 A JP23234398 A JP 23234398A JP 2000053526 A JP2000053526 A JP 2000053526A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- hair
- monomer
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- 239000000178 monomer Substances 0.000 claims abstract description 26
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 239000000470 constituent Substances 0.000 claims description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 20
- -1 antiseptics Substances 0.000 abstract description 5
- 239000006071 cream Substances 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 4
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000000049 pigment Substances 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 239000002250 absorbent Substances 0.000 abstract description 2
- 230000002745 absorbent Effects 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 238000007788 roughening Methods 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 239000004909 Moisturizer Substances 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000001333 moisturizer Effects 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 239000000839 emulsion Substances 0.000 description 16
- 239000006210 lotion Substances 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 230000007423 decrease Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 206010040844 Skin exfoliation Diseases 0.000 description 7
- 230000035618 desquamation Effects 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 5
- 206010037844 rash Diseases 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940106189 ceramide Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 231100000046 skin rash Toxicity 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- PJGSXAZUFMCQKA-UHFFFAOYSA-N 1-bromo-2-dichlorophosphorylethane Chemical compound ClP(Cl)(=O)CCBr PJGSXAZUFMCQKA-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- VKCINEULROICJH-UHFFFAOYSA-N 2-dichlorophosphorylethanol Chemical compound OCCP(Cl)(Cl)=O VKCINEULROICJH-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- QENRKQYUEGJNNZ-UHFFFAOYSA-N 2-methyl-1-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound CC(C)C(S(O)(=O)=O)NC(=O)C=C QENRKQYUEGJNNZ-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- KFNGWPXYNSJXOP-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propane-1-sulfonic acid Chemical compound CC(=C)C(=O)OCCCS(O)(=O)=O KFNGWPXYNSJXOP-UHFFFAOYSA-N 0.000 description 1
- BXYQHDXDCJQOFD-UHFFFAOYSA-N 3-cyanopropanoic acid Chemical compound OC(=O)CCC#N BXYQHDXDCJQOFD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MAGFQRLKWCCTQJ-UHFFFAOYSA-N 4-ethenylbenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(C=C)C=C1 MAGFQRLKWCCTQJ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は化粧料に関し、詳しくは
皮膚に対しては保湿効果や肌荒れ改善効果に優れ、一
方、毛髪に対しては皮膜形成作用に基づく保護効果に優
れた化粧料を提供するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to cosmetics, and more particularly, to cosmetics which are excellent in moisturizing effect and skin roughening effect on skin, while having excellent protective effect on hair based on film forming action. To provide.
【0002】[0002]
【従来の技術】一般に皮膚の乾燥は、皮膚分泌物の量、
特に皮脂分泌量の減退、細胞間脂質やアミノ酸などの天
然保湿因子の減少により、角層のバリア機能が低下し、
経表皮性水分損失(トランス・エピダーマル・ウォータ
ー・ロス、以下、TEWLと略記する)が大きくなった
ときに起こる。従って冬季や、過剰な皮膚洗浄、年齢、
体質などによる皮膚分泌物の減少により皮膚乾燥が増悪
し、角層水分量が10%程度以下に低下した状態を特に
ドライスキンと称している。このように皮膚が乾燥状態
になると皮膚のつやは低下し、小じわが目だつなどの弊
害がでてくる。同様に、毛髪についても毛髪中の水分量
が減少することにより髪はなめらかさを失ない、またつ
やが低下するなどの弊害を生じる。2. Description of the Related Art In general, drying of the skin depends on the amount of skin secretions,
In particular, the decrease in the amount of sebum secretion and the decrease in natural moisturizing factors such as intercellular lipids and amino acids cause the barrier function of the horny layer to decrease
Occurs when transepidermal water loss (hereinafter, abbreviated as TEWL) increases. Therefore, in winter, excessive skin washing, age,
A condition in which skin dryness worsens due to a decrease in skin secretions due to constitution and the like, and a condition in which the water content of the stratum corneum decreases to about 10% or less is particularly called dry skin. As described above, when the skin is in a dry state, the gloss of the skin decreases, and adverse effects such as fine wrinkles appear. Similarly, a decrease in the amount of water in the hair causes the hair to lose its smoothness and to cause other problems such as a decrease in gloss.
【0003】従来、これらの皮膚状態や毛髪状態を改善
するためには、角層や毛髪の水分含有量の低下を防止
し、正常な機能を維持することが必要であり、これまで
各種の方法が研究されてきた。その結果、提案された方
法としては、皮膚との密着性が良く、疎水性を有するワ
セリン軟膏や油中水型乳化物などの閉塞剤を用いてTE
WLを抑制する方法と、吸湿力、保湿力を有する例えば
ヒアルロン酸、キチンなどの多糖類、コラーゲン、エラ
スチンなどの蛋白質類、ソルビトール、エチレングリコ
ール、グリセリンなどの多価アルコール類、およびピロ
リドンカルボン酸ソーダ、乳酸ソーダなどの有機酸塩類
等の吸湿剤、保湿剤を皮膚料基剤中や毛髪料基剤中に配
合することにより、水和効果を高める方法とがあった。
また、最近は角層などの細胞間脂質の一成分であるセラ
ミドやスフィンゴ脂質が水分の保持に重要な働きをして
いることが解明され、合成や天然抽出のセラミドなどを
配合することも行なわれつつある。Conventionally, in order to improve these skin conditions and hair conditions, it has been necessary to prevent a decrease in the water content of the stratum corneum and hair and to maintain a normal function. Has been studied. As a result, the proposed method has a good adhesiveness to the skin and a TE using a hydrophobic vaseline ointment or a water-in-oil emulsion.
A method for suppressing WL and having a hygroscopicity and a moisturizing power, for example, polysaccharides such as hyaluronic acid and chitin, proteins such as collagen and elastin, polyhydric alcohols such as sorbitol, ethylene glycol and glycerin, and sodium pyrrolidone carboxylate There has been a method of enhancing the hydration effect by blending a moisture absorbent such as an organic acid salt such as sodium lactate or the like with a humectant in a skin base or a hair base.
Recently, it was revealed that ceramide and sphingolipids, which are components of intercellular lipids such as the stratum corneum, play an important role in retaining water, and ceramides from synthetic and natural extracts have also been added. It is getting.
【0004】ところが、前記の方法ではいずれも水分保
持能力が充分なものとは言えないばかりか、閉塞剤を用
いた場合は油っぽく、ベタベタするなどの不快な感触を
与える欠点があり、一方、吸湿剤、保湿剤を用いた場合
にも効果を高める為には多量に配合しなければならず、
その結果としてベタベタ感やヌメリ感等の不快な感触を
与えるという問題があり、実際には処方系では多量に配
合することが不可能である。更には経時や微生物に対す
る安定性に劣るという欠点もあった。また、一物質で角
層の吸保湿機能を助ける、ヒアルロン酸のような吸保
湿作用と、セラミド等の細胞間脂質ラメラ層の形成促
進・安定化作用、を併せもつものもない。[0004] However, none of the above methods has a sufficient water retention ability, and the use of an occluding agent has a disadvantage of giving an unpleasant feeling such as oily and sticky. In order to enhance the effect even when using a humectant or a humectant, a large amount must be blended.
As a result, there is a problem that an unpleasant feeling such as a sticky feeling or a slimy feeling is given, and in fact, it is impossible to mix a large amount in a prescription system. Further, there is a disadvantage that the stability with respect to time and microorganisms is poor. Further, there is no compound having both a moisture absorbing and retaining effect such as hyaluronic acid and a promoting and stabilizing effect of formation of an intercellular lipid lamellar layer such as ceramide, which assists the moisture absorbing and retaining function of the stratum corneum with one substance.
【0005】これらの問題点を解決する技術として、2
−メタクリロイルオキシエチルホスホリルコリン重合体
を配合することが提案されている(特開平6−1572
69号)が、さらに感触にすぐれ、効果の高い技術が求
められている。As a technique for solving these problems, 2
-It has been proposed to incorporate a methacryloyloxyethyl phosphorylcholine polymer (Japanese Patent Application Laid-Open No. 6-1572).
No. 69), however, there is a demand for a technique that is more excellent in feel and has a high effect.
【0006】本発明は斯かる実情に鑑みてなされたもの
であって、肌あれ、つや不足等の乾燥に起因する皮膚及
び毛髪状態を改善し、充分な水分保持により潤いを与え
る、いわゆる美肌及び美髪効果を有するとともに、感触
的にも問題の殆んどない化粧料を提供することを課題と
する。The present invention has been made in view of the above circumstances, and is intended to improve the condition of skin and hair caused by dryness such as rough skin and lack of luster, and to provide moisturizing by sufficient moisture retention. It is an object of the present invention to provide a cosmetic composition having a beautiful hair effect and having almost no problem in feel.
【0007】[0007]
【課題を解決するための手段】本発明者は、上記課題を
解決するため鋭意研究を行なった結果、下記一般式
(1)で表されるモノマー(A)を構成単位に含む重合
体と、下記一般式(2)で表されるモノマー(B)を構
成単位に含む重合体とを化粧料に配合してやると、吸
湿、保湿作用に基づく水分保持機能がきわめて高くなる
こと、また感触的にも非常に優れることを見い出し、こ
れに基づいて本発明を完成した。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned problems, and as a result, a polymer containing a monomer (A) represented by the following general formula (1) in a constitutional unit: When a cosmetic containing a polymer containing the monomer (B) represented by the following general formula (2) in a constituent unit is blended into a cosmetic, the moisture retention function based on the moisture absorption and moisturizing action becomes extremely high, and the feel is also improved. It was found to be very good, and based on this, the present invention was completed.
【0008】[0008]
【化3】 〔式中、G−O−は還元糖の1位水酸基より水素原子を
除いた基を示し、nは2または3を示し、mは1〜5の
いずれかの整数を示し、R1およびR2は同一または異
なって、水素原子またはメチル基を示す。〕Embedded image [Wherein GO- represents a group obtained by removing a hydrogen atom from the 1-position hydroxyl group of the reducing sugar, n represents 2 or 3, m represents an integer of any of 1 to 5, R1 and R2 represent The same or different, and represents a hydrogen atom or a methyl group. ]
【0009】[0009]
【化4】 〔式中、xは2または3を示し、yは1〜5のいずれか
の整数を示し、R3およびR4は同一または異なって、
水素原子またはメチル基を示す。〕Embedded image [In the formula, x represents 2 or 3, y represents an integer of any of 1 to 5, R3 and R4 are the same or different,
Shows a hydrogen atom or a methyl group. ]
【0010】すなわち、本発明は、前記一般式(1)で
表されるモノマー(A)を構成単位に含む重合体と前記
一般式(2)で表されるモノマー(B)を構成単位に含
む重合体とを含有することを特徴とする化粧料である。That is, the present invention comprises a polymer containing the monomer (A) represented by the general formula (1) in the structural unit and a monomer (B) represented by the general formula (2) in the structural unit. A cosmetic comprising a polymer.
【0011】以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
【0012】本発明に適用される重合体は、下記一般式
(1)で表されるモノマー(A)を構成単位に含む重合
体と、下記一般式(2)で表されるモノマー(B)を構
成単位に含む重合体である。かかる重合体は、おのおの
のモノマーのホモ重合体であってもよいし、共重合可能
なモノマーとの共重合体であってもよい。共重合可能な
モノマーとしては、例えばメチル(メタ)アクリレー
ト、エチル(メタ)アクリレート、n−ブチル(メタ)
アクリレート、2−エチルヘキシル(メタ)アクリレー
ト、2−ヒドロキシエチル(メタ)アクリレート、2−
ヒドロキシプロピル(メタ)アクリレート等のアクリル
酸エステル又はメタクリル酸エステル、アクリル酸、メ
タクリル酸、クロトン酸、イタコン酸等のカルボキシル
基含有モノエチレン性モノマー、その他スチレン、塩化
ビニル、アクリロニトリル、アクリルアミド、ビニルピ
ロリドン、ポリエチレングリコールモノメタクリレー
ト、2−メタクリロイルオキシエチルメチルスルホキン
ド、アクリルアミド−2−メチル−プロパンスルホン
酸、p−スチレンスルホン酸、3−メタクリロイルオキ
シプロピルスルホン酸、N,N−ジメチルアミノエチル
メタクリレート、N,N−ジエチルアミノエチルメタク
リレート、ビニルピリジン等が挙げられる。The polymer applicable to the present invention includes a polymer containing a monomer (A) represented by the following general formula (1) as a structural unit and a monomer (B) represented by the following general formula (2) Is a polymer containing as a constituent unit. Such a polymer may be a homopolymer of each monomer or a copolymer with a copolymerizable monomer. Examples of the copolymerizable monomer include methyl (meth) acrylate, ethyl (meth) acrylate, and n-butyl (meth).
Acrylate, 2-ethylhexyl (meth) acrylate, 2-hydroxyethyl (meth) acrylate, 2-
Acrylic esters or methacrylic esters such as hydroxypropyl (meth) acrylate, carboxyl group-containing monoethylenic monomers such as acrylic acid, methacrylic acid, crotonic acid, and itaconic acid; other styrene, vinyl chloride, acrylonitrile, acrylamide, vinylpyrrolidone; Polyethylene glycol monomethacrylate, 2-methacryloyloxyethylmethylsulfokind, acrylamido-2-methyl-propanesulfonic acid, p-styrenesulfonic acid, 3-methacryloyloxypropylsulfonic acid, N, N-dimethylaminoethyl methacrylate, N, N -Diethylaminoethyl methacrylate, vinyl pyridine and the like.
【0013】共重合体を用いる場合は、かかるモノマー
(A)もしくは(B)と共重合可能なモノマーとの構成
比率は5:95以上であることが望ましく、好適には2
0:80以上であることが望ましい。When a copolymer is used, the ratio of the monomer (A) or (B) to the copolymerizable monomer is desirably 5:95 or more, preferably 2:95.
0: It is desirable that it is 80 or more.
【0014】[0014]
【化5】 〔式中、G−O−は還元糖の1位水酸基より水素原子を
除いた基を示し、nは2または3を示し、mは1〜5の
いずれかの整数を示し、R1およびR2は同一または異
なって、水素原子またはメチル基を示す。〕Embedded image [Wherein GO- represents a group obtained by removing a hydrogen atom from the 1-position hydroxyl group of the reducing sugar, n represents 2 or 3, m represents an integer of any of 1 to 5, R1 and R2 represent The same or different, and represents a hydrogen atom or a methyl group. ]
【0015】[0015]
【化6】 〔式中、xは2または3を示し、yは1〜5のいずれか
の整数を示し、R3およびR4は同一または異なって、
水素原子またはメチル基を示す。〕Embedded image [In the formula, x represents 2 or 3, y represents an integer of any of 1 to 5, R3 and R4 are the same or different,
Shows a hydrogen atom or a methyl group. ]
【0016】かかるモノマー(A)は下記一般式(3)
で表される化合物に下記一般式(4)で表されるハロゲ
ン化糖を反応させる方法や、下記一般式(5)で表され
る化合物に下記一般式(6)で表される化合物を縮合さ
せる等の方法で合成できる。The monomer (A) is represented by the following general formula (3)
A method of reacting a compound represented by the following general formula (4) with a halogenated sugar represented by the following general formula (4), or condensing a compound represented by the following general formula (6) with a compound represented by the following general formula (5) Can be synthesized.
【0017】[0017]
【化7】 〔式中、nは2または3を示し、mは1〜5のいずれか
の整数を示し、R1およびR2は同一または異なって、
水素原子またはメチル基を示す。〕Embedded image [Wherein, n represents 2 or 3, m represents an integer of 1 to 5, R1 and R2 are the same or different,
Shows a hydrogen atom or a methyl group. ]
【0018】[0018]
【化8】 Embedded image
【0019】[0019]
【化9】 〔式中、R1およびR2は同一または異なって、水素原
子またはメチル基を示す。〕Embedded image [Wherein, R1 and R2 are the same or different and each represent a hydrogen atom or a methyl group. ]
【0020】[0020]
【化10】 〔式中、G−O−は還元糖の1位水酸基より水素原子を
除いた基を示し、nは2または3を示し、mは1〜5の
いずれかの整数を示す。〕Embedded image [Wherein GO- represents a group in which a hydrogen atom has been removed from the 1-position hydroxyl group of the reducing sugar, n represents 2 or 3, and m represents an integer of 1 to 5. ]
【0021】モノマー(B)については、例えば2−ブ
ロモエチルホスホリルジクロリドと2−ヒドロキシエチ
ルホスホリルジクロリドと2−ヒドロキシエチルメタク
リレートとを反応させて2−メタクリロイルオキシエチ
ル−2′−ブロモエチルリン酸を得、更にこれをトリメ
チルアミンとメタノール溶液中で反応させて得ることが
できる。(高分子論文集,Vol.35,P423〜4
27,1978)For the monomer (B), for example, 2-bromoethyl phosphoryl dichloride, 2-hydroxyethyl phosphoryl dichloride and 2-hydroxyethyl methacrylate are reacted to obtain 2-methacryloyloxyethyl-2'-bromoethyl phosphoric acid. And further reacted with trimethylamine in a methanol solution. (Polymer Transactions, Vol. 35, pp. 423-4)
27, 1978)
【0022】次に、それぞれの重合体の製造方法につい
ては常法に従えば良く、モノマーを溶媒中で重合開始剤
の存在下、反応させて得られる。ここで使用される溶媒
としては、モノマー(A)、(B)が溶解するものであ
れば良く、具体的には水、メタノール、エタノール、プ
ロパノール、t−ブタノール、ベンゼン、トルエン、ジ
メチルホルムアミド、テトラヒドロフラン、クロロホル
ムまたはこれらの混合溶媒等が例示される。また、重合
開始剤としては、通常のラジカル開始剤ならば何れを用
いても良く、2,2′−アゾビスイソブチロニトリル
(AIBN)、3−カルボキシプロピオニトリル、アゾ
ビスマレノニトリル等の脂肪酸アゾ化合物や過酸化ベン
ゾイル、t−ブチルパーオキサイド、過酸化ラウロイ
ル、過硫酸カリウム等の有機過酸化物を挙げることがで
きる。Next, the production method of each polymer may be in accordance with a conventional method, and is obtained by reacting a monomer in a solvent in the presence of a polymerization initiator. The solvent used here may be any solvent in which the monomers (A) and (B) can be dissolved, and specifically, water, methanol, ethanol, propanol, t-butanol, benzene, toluene, dimethylformamide, tetrahydrofuran , Chloroform or a mixed solvent thereof. As the polymerization initiator, any ordinary radical initiator may be used, and examples thereof include 2,2'-azobisisobutyronitrile (AIBN), 3-carboxypropionitrile, and azobismalenonitrile. Examples include fatty acid azo compounds and organic peroxides such as benzoyl peroxide, t-butyl peroxide, lauroyl peroxide, and potassium persulfate.
【0023】上記の如き方法で得られる本発明に係る重
合体の分子量は、その使用目的に応じて種々調整するこ
とができるが、感触面、ゲル化能、皮膜形成能等を勘案
した場合、通常はポリエチレングリコール(PEG)換
算で5,000以上であり、好ましくは10,000以
上である。すなわち、重合体の分子量がこれより小さく
なると、水分保持機能やラメラ形成促進安定化作用が低
下して好ましくない。The molecular weight of the polymer according to the present invention obtained by the above-mentioned method can be variously adjusted according to the purpose of use, but in consideration of a touch surface, a gelling ability, a film forming ability and the like, Usually, it is 5,000 or more, preferably 10,000 or more, in terms of polyethylene glycol (PEG). That is, if the molecular weight of the polymer is smaller than this, the water retention function and the lamella formation promoting / stabilizing effect are undesirably reduced.
【0024】本発明の化粧料では、上記重合体の合計量
として化粧料全体に対して、通常0.001〜10重量
%、好ましくは0.01〜3重量%の範囲で含有され
る。In the cosmetic of the present invention, the total amount of the above-mentioned polymer is usually 0.001 to 10% by weight, preferably 0.01 to 3% by weight, based on the total amount of the cosmetic.
【0025】重合体の併用の比率としては、モノマー
(A)を構成単位に含む重合体とモノマー(B)を構成
単位に含む重合体の比率が1:10〜10:1の範囲が
好ましい。この範囲をはずれると、各重合体を単独で用
いる場合と大差がなくなり、本発明の効果を十分発揮で
きない。The ratio of the combined use of the polymers is preferably such that the ratio of the polymer containing the monomer (A) in the constitutional unit to the polymer containing the monomer (B) in the constitutional unit is from 1:10 to 10: 1. If it is out of this range, there is no great difference from the case where each polymer is used alone, and the effect of the present invention cannot be sufficiently exhibited.
【0026】また、本発明の化粧料は、化粧水、乳液、
クリーム、口紅、ファンデーションなどの形態で皮膚化
粧料として用いることができ、一方、ヘアートニック、
ヘアークリーム、ヘアーローションなどの形態で毛髪化
粧料として用いることができる。更に、重合体のゲル化
能、皮膜形成能を利用してマッサージ料やパック料とし
て用いることもできる。尚、これらの化粧料は常法に従
って製造することができる。Further, the cosmetic of the present invention comprises a lotion, an emulsion,
It can be used as a skin cosmetic in the form of creams, lipsticks, foundations, etc.
It can be used as a hair cosmetic in the form of a hair cream, a hair lotion or the like. Further, it can be used as a massage charge or a pack charge by utilizing the gelling ability and the film forming ability of the polymer. In addition, these cosmetics can be manufactured according to a conventional method.
【0027】更に、本発明の化粧料には重合体に加え
て、必要に応じて界面活性剤、粉体または顔料、酸化防
止剤、紫外線吸収剤、保湿剤、ビタミン類、防腐剤、香
料などを配合できる。Further, in addition to the polymer, the cosmetic of the present invention may further contain, if necessary, a surfactant, a powder or a pigment, an antioxidant, an ultraviolet absorber, a humectant, a vitamin, a preservative, a fragrance, etc. Can be blended.
【0028】ここで、モノマー(A)を構成成分とする
重合体とモノマー(B)を構成成分とする重合体を配合
してやると如何に優れた吸湿特性を発揮するかの評価を
するための実験を行なった。その内容を以下に示す。Here, an experiment was conducted to evaluate how excellent a moisture absorbing property is exhibited when a polymer containing the monomer (A) and a polymer containing the monomer (B) are blended. Was performed. The contents are shown below.
【0029】実験1.重合体の吸湿性 〔サンプル〕 モノマー(A)のホモ重合体として、ポ
リグルコシルオキシエチルメタクリレート(以下、P−
GEMAと略記する)を、モノマー(B)のホモ重合体
として、ポリメタクリロイルオキシエチルホスホリルコ
リン(以下、P−MPCと略記する)を用いて吸湿性の
実験を行った。 (1)P−GEMA(分子量10,000) (2)P−MPC (分子量8,000) (3)キトサンExperiment 1 Hygroscopicity of polymer [Sample] As a homopolymer of monomer (A), polyglucosyloxyethyl methacrylate (hereinafter referred to as P-
GEMA) was used as a homopolymer of the monomer (B) and polymethacryloyloxyethyl phosphorylcholine (hereinafter abbreviated as P-MPC) was used to conduct an experiment on hygroscopicity. (1) P-GEMA (molecular weight 10,000) (2) P-MPC (molecular weight 8,000) (3) chitosan
【0030】〔測定方法〕P−GEMAの50%エタノ
ール溶液(5重量%)、P−MPCの50%エタノール
溶液(5重量%)、P−GEMAとP−MPCの50%
エタノール溶液(1:1、合計5重量%)、キトサンの
酢酸水溶液(5重量%)を調製し、各溶液5mlを25
cm2 のテフロン板上に流延した後、室温にて溶媒を揮散
させ、厚さ約100μmの膜を作成した。これを、飽和
塩溶液により各相対湿度(60%、80%、95%)に
調整したデシケーター中に入れ、20℃以下、48時間
後の重量増加率を測定した。その結果を図1に示す。 重量増加率(%)=〔(48hr後の重量−初期重量)
/初期重量〕×100[Measurement method] 50% ethanol solution of P-GEMA (5% by weight), 50% ethanol solution of P-MPC (5% by weight), 50% of P-GEMA and P-MPC
An ethanol solution (1: 1, total 5% by weight) and an aqueous solution of chitosan in acetic acid (5% by weight) were prepared.
After casting on a Teflon plate of cm 2, the solvent was volatilized at room temperature to form a film having a thickness of about 100 μm. This was placed in a desiccator adjusted to each relative humidity (60%, 80%, 95%) with a saturated salt solution, and the weight increase rate after 20 hours or less and 20 hours or less was measured. The result is shown in FIG. Weight increase rate (%) = [(weight after 48 hours−initial weight)
/ Initial weight] x 100
【0031】〔結果〕図1の結果から明らかな如く、本
発明に係るP−GEMAとP−MPCを併用した系は、
比較品であるP−GEMA単独、P−MPC単独、キト
サンに比べて高い吸湿性を示すことが示された。[Results] As is clear from the results shown in FIG. 1, the system using both P-GEMA and P-MPC according to the present invention is:
It was shown to exhibit higher hygroscopicity than the comparative products P-GEMA alone, P-MPC alone, and chitosan.
【0032】[0032]
【実施例】以下に、本発明の化粧料の実施例を示す。
尚、配合割合は重量%である。EXAMPLES Examples of the cosmetic of the present invention will be shown below.
The mixing ratio is% by weight.
【0033】 実施例1.O/W型乳液 ステアリン酸 1 ミツロウ 2 マイクロクリスタリンワックス 1 P−MPC 3%水溶液(分子量20,000) 15 P−GEMA 3%水溶液(分子量10,000) 15 プロピレングリコール 5 グリセリン 2 エチルアルコール 5 防腐剤 0.3 香 料 0.3 精製水 53.4Embodiment 1 O / W type emulsion Stearic acid 1 Beeswax 2 Microcrystalline wax 1 P-MPC 3% aqueous solution (molecular weight 20,000) 15 P-GEMA 3% aqueous solution (molecular weight 10,000) 15 Propylene glycol 5 Glycerin 2 Ethyl alcohol 5 Preservative 0.3 Fragrance 0.3 Purified water 53.4
【0034】 実施例2.化粧水 P−MPC 2%水溶液(分子量20,000) 15 P−GEMA 3%水溶液(分子量5,000) 10 グリセリン 1.5 エタノール 6 プロピレングリコール 1.5 クエン酸 0.01 クエン酸ナトリウム 0.1 香 料 0.05 精製水 65.84Embodiment 2 Lotion P-MPC 2% aqueous solution (molecular weight 20,000) 15 P-GEMA 3% aqueous solution (molecular weight 5,000) 10 Glycerin 1.5 Ethanol 6 Propylene glycol 1.5 Citric acid 0.01 Sodium citrate 0.1 Flavor 0.05 Purified water 65.84
【0035】 実施例3.クリーム スクワラン 5 2−エチルヘキサン酸トリグリセライド 1 ワセリン 0.5 P−MPC 3%水溶液(分子量10,000) 20 P−GEMA 2%水溶液(分子量8,000) 30 グリセリン 3 1,3−ブタンジオール 4 ポリグリセリンポリオキシブチレンステアリルエーテル 2.5 香 料 0.2 精製水 33.8Embodiment 3 Cream squalane 5 2-ethylhexanoic acid triglyceride 1 petrolatum 0.5 P-MPC 3% aqueous solution (molecular weight 10,000) 20 P-GEMA 2% aqueous solution (molecular weight 8,000) 30 glycerin 3 1,3-butanediol 4 poly Glycerin polyoxybutylene stearyl ether 2.5 Fragrance 0.2 Purified water 33.8
【0036】 実施例4.ヘアーローション P−MPC 2%水溶液(分子量40,000) 3 P−GEMA 3%水溶液(分子量15,000) 2 エタノール 10 グリセリン 3 カルボキシメチルキチン 0.01 ビタミンE 0.1 色 素 0.02 精製水 81.87Embodiment 4 Hair lotion P-MPC 2% aqueous solution (molecular weight 40,000) 3 P-GEMA 3% aqueous solution (molecular weight 15,000) 2 ethanol 10 glycerin 3 carboxymethyl chitin 0.01 vitamin E 0.1 pigment 0.02 purified water 81.87
【0037】 実施例5.ヘアークリーム スクワラン 30.0 ワセリン 3.0 ミツロウ 4.0 ステアリン酸 4.0 オリーブ油 2.0 ソルビタンモノステアレート 2.5 ポリオキシエチレンソルビタンモノステアレート 2.5 ブチルパラベン 0.1 P−MPC 10%水溶液(分子量20,000) 10 P−GEMA 2%水溶液(分子量10,000) 20 1,3−ブタンジオール 2.5 ポリエチレングリコール200 1.5 トリエタノールアミン 1.0 メチルパラベン 0.1 香 料 0.2 精製水 16.6Embodiment 5 Hair Cream Squalane 30.0 Vaseline 3.0 Beeswax 4.0 Stearic Acid 4.0 Olive Oil 2.0 Sorbitan Monostearate 2.5 Polyoxyethylene Sorbitan Monostearate 2.5 Butyl Paraben 0.1 P-MPC 10% Aqueous solution (molecular weight 20,000) 10 P-GEMA 2% aqueous solution (molecular weight 10,000) 20 1,3-butanediol 2.5 polyethylene glycol 200 1.5 triethanolamine 1.0 methylparaben 0.1 flavor 0. 2 Purified water 16.6
【0038】(比較実験)本発明により得られた化粧料
と従来の化粧料とを肌荒れ改善効果及び毛髪保護効果に
より比較した。(Comparative Experiment) The cosmetic obtained according to the present invention was compared with a conventional cosmetic in terms of an effect of improving rough skin and an effect of protecting hair.
【0039】実験2.人工的な肌荒れの改善効果 〔サンプル〕 (ア)本発明の実施例1の乳液 (イ)本発明の実施例1の乳液からP−MPCを除去
(水を増量)した乳液 (ウ)本発明の実施例1の乳液からP−GEMAを除去
(水を増量)した乳液Experiment 2 (Sample) (A) Emulsion of Example 1 of the present invention (A) Emulsion obtained by removing P-MPC (increased water) from the emulsion of Example 1 of the present invention (C) The present invention Emulsion obtained by removing P-GEMA from the emulsion of Example 1 (increased amount of water)
【0040】〔実験方法〕邦人女性10人(年令20〜
37才)を被験者として、界面活性剤による人工的な肌
荒れに対する改善効果を角層水分量の測定及び皮疹の判
定により行なった。すなわち、前腕内側部の皮膚を対象
とし、これに直径3cmのガラスコップを密着させ、そこ
へ10mlの5%ドデシル硫酸ナトリウム(SDS)を
入れ軽く揺らしながら10分間放置した後処理液を回収
し、さらに同一部位に次の20分間同一の処理液で放置
した後処理液を回収して肌荒れを惹起させた。このSD
S処理の1日後から、処理部位に1日2回当りサンプル
(ア)または(イ)または(ウ)の乳液を塗布した。実
験前後の角層水分量を下記測定法に従い皮表コンダクタ
ンス値として測定した結果および皮疹を下記判定基準に
従って判定した結果(平均値)を図2及び図3に示す。[Experimental Method] Ten Japanese women (age 20-
The effect of the surfactant on the improvement of artificial skin roughness was measured by measuring the water content of the stratum corneum and judging skin eruption with a subject (age 37). That is, a glass cup having a diameter of 3 cm was adhered to the skin on the inner part of the forearm, 10 ml of 5% sodium dodecyl sulfate (SDS) was put therein, and the mixture was allowed to stand for 10 minutes while gently shaking. After leaving the same site for the next 20 minutes with the same processing solution, the processing solution was recovered to cause rough skin. This SD
One day after the S treatment, an emulsion of the sample (A), (A) or (C) was applied to the treated site twice a day. FIGS. 2 and 3 show the results of measuring the horny layer water content before and after the experiment as skin surface conductance values according to the following measurement method, and the results (mean values) of skin rashes determined according to the following criteria.
【0041】1)角層水分量の測定 角層の水分量は田上らの方法に従いキャパシタンス・コ
ンダクタンス・メーター(IBM社MODEL IB−
354)を用いて測定する。測定に際しては測定部位皮
膚を37℃の温水で30秒間洗浄後、20℃,50%相
対湿度下、5回測定してその平均を測定値とする。1) Measurement of the water content of the stratum corneum The water content of the stratum corneum was measured in accordance with the method of Tagami et al. Using a capacitance conductance meter (IBM Model IB-
354). At the time of measurement, the skin at the measurement site is washed with warm water of 37 ° C. for 30 seconds, and then measured five times at 20 ° C. and 50% relative humidity, and the average is taken as the measured value.
【0042】2)皮疹判定基準 0:乾燥性落屑性変化を認めない。 1:かすかな乾燥性落屑性変化を認める。(かすかな落
屑または光沢) 2:明瞭な乾燥性落屑性変化を認める。(処理部の境界
が明瞭で、明瞭な落屑に一部光沢、亀裂) 3:著しい乾燥性落屑性変化を認める。(明瞭な落屑に
明瞭な光沢、亀裂)2) Evaluation criteria for skin rash 0: No dry desquamation change is observed. 1: A slight drying desquamation change is recognized. (Faint desquamation or gloss) 2: A clear drying desquamation change is recognized. (The boundary of the treated part is clear, and clear desquamation is partially glossy and cracked.) 3: A remarkable change in desiccation and desquamation is recognized. (Clear luster, crack on clear desquamation)
【0043】図2及び図3の結果に示された如く、本発
明品の乳液であるサンプル(ア)は、従来品の乳液であ
るサンプル(イ)、(ウ)に比し、角層水分量の回復
(皮表コンダクタンス値の上昇)や乾燥性皮疹に対して
著しい効果のあることが実証された。As shown in the results of FIGS. 2 and 3, the sample (A) which is the emulsion of the product of the present invention has a higher water content of the stratum corneum than the samples (A) and (C) which are the emulsions of the conventional product. It was demonstrated to have a significant effect on the recovery of the amount (increased skin conductance) and on the dry eruption.
【0044】実験3.実使用テスト 〔サンプル〕実験3で使用したサンプル(ア)、(イ)
及び(ウ)の乳液と同一のものを用いた。Experiment 3 Actual use test [Sample] Samples used in Experiment 3 (A), (A)
The same emulsion as in (c) was used.
【0045】〔実験方法〕日頃から肌荒れ、乾燥性の症
状を訴える邦人女性60人(年令20〜49才)を無作
為にA群、B群、C群(各20人)に分け、A群にはサ
ンプル(ア)の乳液を、B群にはサンプル(イ)の乳液
を、C群にはサンプル(ウ)の乳液をそれぞれ1ヶ月間
使用してもらった。1ヶ月後のしっとり感(保水効
果)、肌のはりの改善(賦活効果)などの美肌効果と使
用中の感触(ベたつき感)について群間比較を行なっ
た。その結果を表1に示す。[Experimental Method] 60 Japanese women (aged 20 to 49 years old) who complain of rough skin and dryness on a regular basis were randomly divided into groups A, B and C (20 each). The group used the emulsion of the sample (a), the group B used the emulsion of the sample (a), and the group C used the emulsion of the sample (c) for one month. A comparison was made between groups regarding the beautiful skin effect such as moist feeling (water retention effect) and improvement of skin swelling (activation effect) after one month and the feel during use (stickiness). Table 1 shows the results.
【0046】[0046]
【表1】 [Table 1]
【0047】表1の結果から明らかなように、本発明品
の乳液であるサンプル(ア)は、従来品の乳液であるサ
ンプル(イ)、(ウ)と同様に感触的な問題もなく、一
方、保水効果や賦活効果等の美肌効果については格段に
優れていることが実証された。As is evident from the results in Table 1, the sample (A), which is an emulsion of the product of the present invention, has no tactile problem similarly to the samples (A) and (C) which are emulsions of the conventional product. On the other hand, it was proved that the skin beautiful effects such as the water retention effect and the activation effect were remarkably excellent.
【0048】実験4.毛髪保護効果 〔サンプル〕 (エ)本発明の実施例4のヘアーローション (オ)本発明の実施例4のヘアーローションからP−M
PCを除去(水を増量)したヘアーローション (カ)本発明の実施例4のヘアーローションからP−G
EMAを除去(水を増量)したヘアーローションExperiment 4 Hair protection effect [Sample] (D) Hair lotion of Example 4 of the present invention (E) PM from hair lotion of Example 4 of the present invention
Hair lotion from which PC was removed (water was increased) (f) PG from the hair lotion of Example 4 of the present invention
Hair lotion with EMA removed (increased water)
【0049】〔実験方法〕これまでパーマ、ブリーチ等
の処理を行なったことのない邦人女性の毛髪10g(長
さ10cm)を束ね、これにサンプル(エ)または(オ)
または(カ)のヘアーローションの所定量を塗布した
後、風乾した。評価は、専門パネラー5名により下記表
2に示す基準に従って官能評価し、その平均点を表3に
示した。尚、評価項目は毛髪の平滑性、つやならびにし
っとり感(保湿性)について行なった。[Experimental method] A bundle of 10 g (length 10 cm) of Japanese female hair, which had not been subjected to a permanent or bleaching treatment, was bundled with a sample (D) or (E).
Alternatively, after applying a predetermined amount of the hair lotion (f), the hair lotion was air-dried. The evaluation was performed by five expert panelists according to the criteria shown in Table 2 below, and the average score was shown in Table 3. The evaluation items were for hair smoothness, gloss and moist feeling (moisturizing property).
【0050】[0050]
【表2】 [Table 2]
【0051】[0051]
【表3】 [Table 3]
【0052】表4の結果に示された如く、本発明品のヘ
アーローションであるサンプル(エ)は、従来品のヘア
ーローションであるサンプル(オ)、(カ)に比し、毛
髪の平滑性、つやならびにしっとり感の何れにおいても
優れていることが明らかとなった。As shown in the results in Table 4, the sample (d), which is the hair lotion of the product of the present invention, is smoother than the samples (e) and (f), which are the hair lotions of the conventional product. It was clear that both the gloss and the moist feeling were excellent.
【0053】[0053]
【発明の効果】本発明によれば、水分保持機能、ラメラ
形成促進・安定化作用ならびに皮膜形成能等に基づく皮
膚に対する美肌効果、また毛髪に対する美髪効果が格段
に優れていることは勿論のこと、安定性上の問題もなく
使用することができる。According to the present invention, of course, the skin-beautifying effect on the skin and the hair-beautifying effect on the hair based on the water retention function, the lamellar formation promoting / stabilizing action, the film forming ability and the like are remarkably excellent. It can be used without any stability problems.
【図1】相対湿度と重量増加率の関係を示す図である。FIG. 1 is a diagram showing the relationship between relative humidity and weight increase rate.
【図2】日数と皮表コンダクタンス値の関係を示す図で
ある。FIG. 2 is a diagram showing a relationship between the number of days and a skin conductance value.
【図3】日数と皮疹との関係を示す図である。FIG. 3 is a diagram showing the relationship between the number of days and rash.
【化1】 Embedded image
【化2】 Embedded image
【化11】 Embedded image
【化12】 Embedded image
───────────────────────────────────────────────────── フロントページの続き (72)発明者 神保 和子 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 Fターム(参考) 4C083 AA082 AA122 AC012 AC022 AC102 AC122 AC182 AC242 AC302 AC422 AC442 AC482 AC542 AC691 AC901 AD042 AD131 AD132 AD322 AD391 AD392 AD672 CC01 CC04 CC05 CC32 DD31 DD33 EE06 EE07 EE12 EE29 ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Kazuko Jimbo 27-1 Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Prefecture F-term in the Yokohama Research Laboratory, Polar Chemical Industry Co., Ltd. 4C083 AA082 AA122 AC012 AC022 AC102 AC122 AC182 AC242 AC302 AC422 AC442 AC482 AC542 AC691 AC901 AD042 AD131 AD132 AD322 AD391 AD392 AD672 CC01 CC04 CC05 CC32 DD31 DD33 EE06 EE07 EE12 EE29
Claims (2)
(A)〔式中、G−O−は還元糖の1位水酸基より水素
原子を除いた基を示し、nは2または3を示し、mは1
〜5のいずれかの整数を示し、R1およびR2は同一ま
たは異なって、水素原子またはメチル基を示す。〕を構
成単位に含む重合体と、下記一般式(2)で表されるモ
ノマー(B)〔式中、xは2または3を示し、yは1〜
5のいずれかの整数を示し、R3およびR4は同一また
は異なって、水素原子またはメチル基を示す。〕を構成
単位に含む重合体とを含有することを特徴とする化粧
料。1. A monomer (A) represented by the following general formula (1): wherein GO- is a group obtained by removing a hydrogen atom from the 1-position hydroxyl group of a reducing sugar, and n is 2 or 3. Where m is 1
And R1 and R2 are the same or different and each represent a hydrogen atom or a methyl group. And a monomer (B) represented by the following general formula (2) wherein x represents 2 or 3, and y represents 1 to
5 represents any integer, and R3 and R4 are the same or different and each represent a hydrogen atom or a methyl group. ] Which is a constituent unit of a cosmetic.
の水酸基より水素原子を除いた基が、グルコース、マン
ノース、ガラクトース、アラビノース、キシロース、リ
ボース、マルトース、ラクトース、セロビオース、マル
トオリゴ糖の1位の水酸基より水素原子を除いた基から
なる群から選ばれる1種または2種以上である請求項1
に記載の化粧料。2. A group in which a hydrogen atom has been removed from the 1-position hydroxyl group represented by G—O— in the general formula (1) is glucose, mannose, galactose, arabinose, xylose, ribose, maltose, lactose, cellobiose, 2. One or more selected from the group consisting of a group obtained by removing a hydrogen atom from the hydroxyl group at position 1 of maltooligosaccharide.
The cosmetic according to any one of the above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23234398A JP3626603B2 (en) | 1998-08-04 | 1998-08-04 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23234398A JP3626603B2 (en) | 1998-08-04 | 1998-08-04 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000053526A true JP2000053526A (en) | 2000-02-22 |
JP3626603B2 JP3626603B2 (en) | 2005-03-09 |
Family
ID=16937728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP23234398A Expired - Fee Related JP3626603B2 (en) | 1998-08-04 | 1998-08-04 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3626603B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003160462A (en) * | 2001-11-21 | 2003-06-03 | Pola Chem Ind Inc | Functional skin care preparation having barrier function |
JP2003327760A (en) * | 2002-05-13 | 2003-11-19 | Nof Corp | Emulsified product of polybutene and water |
JP2005306796A (en) * | 2004-04-23 | 2005-11-04 | Pola Chem Ind Inc | Skin care external preparation having anti-inflammatory activity |
JP2015209391A (en) * | 2014-04-25 | 2015-11-24 | クラシエホームプロダクツ株式会社 | Hair cosmetics |
-
1998
- 1998-08-04 JP JP23234398A patent/JP3626603B2/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003160462A (en) * | 2001-11-21 | 2003-06-03 | Pola Chem Ind Inc | Functional skin care preparation having barrier function |
JP2003327760A (en) * | 2002-05-13 | 2003-11-19 | Nof Corp | Emulsified product of polybutene and water |
JP2005306796A (en) * | 2004-04-23 | 2005-11-04 | Pola Chem Ind Inc | Skin care external preparation having anti-inflammatory activity |
JP2015209391A (en) * | 2014-04-25 | 2015-11-24 | クラシエホームプロダクツ株式会社 | Hair cosmetics |
Also Published As
Publication number | Publication date |
---|---|
JP3626603B2 (en) | 2005-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2832119B2 (en) | Cosmetics | |
JP2931703B2 (en) | Cosmetics | |
DE60028435T2 (en) | Use of at least one silicone graft polymer as a tightening agent | |
JPS58213705A (en) | Skin conditioning composition | |
AU2011200440B2 (en) | Silicone elastomer exfoliating compositions | |
EP2394633A2 (en) | Method of cleansing skin having an impaired barrier | |
JP2992416B2 (en) | Cosmetics | |
JP2992415B2 (en) | Cosmetics | |
JP2000063261A (en) | Reparation for external use for skin | |
JPH10279466A (en) | Preparation for external use | |
US8357355B2 (en) | Silicone elastomer exfoliating compositions | |
JP2000053526A (en) | Cosmetic | |
BR112018001974B1 (en) | COMPOSITION FOR PERSONAL CARE, AND METHODS FOR LIGHTENING SKIN TONE AND TO IMPROVE VISIBLE LIGHT DISPERSION OF A COMPOSITION | |
JP3104938B2 (en) | Cosmetics | |
JP4310008B2 (en) | Cosmetics | |
CN105992582B (en) | External preparation for skin | |
JP2000053525A (en) | Cosmetic | |
JPH10279427A (en) | Moisture-retaining cosmetic material composition | |
CN110496065A (en) | Moisturizing composition | |
JP2002060332A (en) | Cosmetic for skin | |
JP2001002554A (en) | Skin protective composition | |
JP2000178125A (en) | Cosmetics for skin | |
CA2999497A1 (en) | Methods of improving the activity of retinoids | |
JPH04230613A (en) | Pack material for cosmetic | |
CN118526421A (en) | Body lotion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040525 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040722 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041130 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20041203 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131210 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |